Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,832 | 17,909 | 18,555 | 19,780 | 8,535 |
| Receivables | 3,095 | 5,546 | 4,230 | 3,965 | 3,058 |
| Inventories | 9,551 | 8,602 | 7,468 | 7,617 | 6,741 |
| TOTAL | $21,510 | $33,165 | $30,473 | $31,870 | $18,861 |
| Non-Current Assets | |||||
| PPE Net | 10,426 | 10,230 | 10,544 | 5,755 | 5,953 |
| Intangibles | 6,341 | 6,634 | 6,634 | 6,634 | 6,634 |
| Other Non-Current Assets | 2,618 | 2,687 | 2,693 | 3,850 | 3,701 |
| TOTAL | $19,386 | $19,551 | $19,871 | $16,239 | $16,288 |
| Total Assets | $40,896 | $52,716 | $50,343 | $48,108 | $35,149 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 311 | 471 | 503 | 435 | 354 |
| Accounts payable and accrued liabilities | 2,447 | 1,472 | 1,724 | 1,614 | 1,431 |
| Accrued Expenses | 5,048 | 4,676 | 4,579 | 4,810 | 4,693 |
| TOTAL | $7,834 | $6,654 | $6,843 | $7,080 | $6,694 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,562 | 15,489 | 15,532 | 13,207 | 1,389 |
| Deferred Revenues | 13 | 13 | 13 | 13 | 13 |
| Other Non-Current Liabilities | 522 | 376 | 751 | 2,260 | 1,812 |
| TOTAL | $4,102 | $15,887 | $16,309 | $15,495 | $3,233 |
| Total Liabilities | $11,936 | $22,542 | $23,152 | $22,575 | $9,927 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,013,915 | 1,013,915 | 1,013,915 | 1,011,282 | 1,011,282 |
| Common Shares | 1,014 | 1,014 | 1,014 | 1,011 | 1,011 |
| Retained earnings | -136,498 | -135,269 | -138,239 | -139,754 | -140,060 |
| Other shareholders' equity | -307 | -307 | -307 | -307 | -307 |
| TOTAL | $28,960 | $30,175 | $27,191 | $25,533 | $25,222 |
| Total Liabilities And Equity | $40,896 | $52,716 | $50,343 | $48,108 | $35,149 |